Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

Study Overview
=================
Brief Summary
-----------------
The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments

Detailed Description
-----------------
In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive endodontic medications (Eugenol or Articaine) in order to determine which one is the more efficient to control the pain. These patients would have received the same medication without this study. That's why this is an obsevationnal study.

Official Title
-----------------
Articaine or Eugenol: a Study on the Choice of Endodontic Medication in the Emergency Management of Irreversible Pulpitis of a Mature Permanent Tooth

Conditions
-----------------
Toothaches, Pulpitides, Endodontic Inflammation, Operative Dentistry

Intervention / Treatment
-----------------
* Drug: Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne
* Drug: Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patient, major, affiliated to a social health insurance scheme Patient having agreed to participate in the study Urgent consultant patient for irreversible pulpitis Patient understanding French Exclusion Criteria: Refusal of the patient to participate in the study Impossibility of performing the surgical procedure Impossibility to give the subject information enlightened (difficulty of understanding ...) Subject under the protection of justice, or under guardianship General contraindication to endodontic treatment in 2 sessions (high risk of infectious endocarditis, for example) Chronic intake of analgesic drugs

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Articaïne<br> | Drug: Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne<br>* Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne<br>|
| Eugénol<br> | Drug: Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol<br>* Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Pain evolution (decrease or increase the intensity of the pain) | Evolution of pain (using a score of 0 to 10) | 7 days |